GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (OTCPK:ORYZF) » Definitions » Inventories, Other

ORYZF (Oryzon Genomics) Inventories, Other : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Oryzon Genomics Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Oryzon Genomics's other inventories for the quarter that ended in Sep. 2024 was $0.00 Mil.


Oryzon Genomics Inventories, Other Historical Data

The historical data trend for Oryzon Genomics's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics Inventories, Other Chart

Oryzon Genomics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oryzon Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oryzon Genomics Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Oryzon Genomics Business Description

Traded in Other Exchanges
Address
Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.

Oryzon Genomics Headlines

From GuruFocus

ORYZON to Hold Multiple Corporate Activities in January

By GuruFocusNews GuruFocusNews 01-03-2022

Oryzon Genomics (ORY): Planning Iadademstat's Path to Market

By ACCESSWIRE ACCESSWIRE 02-10-2022